A*STAR Bioinformatics Institute (A*STAR BII)

Multidisciplinary efforts across A*STAR are paving the way toward Singapore’s precision medicine vision.

A user-friendly online computational platform helps researchers scour complex datasets to predict how likely food proteins are to trigger allergic reactions.

A*STAR scientists lay the foundations for a circular economy using worms that turn plastics into fertiliser.

A computational model developed at A*STAR provides insights on how molecular dynamics of proteins impact their function, unlocking new precision medicine opportunities.

A novel molecular mechanism by which a malarial parasite enters host cells may broaden possibilities in malaria vaccine development.

SARS-CoV-2 genome structures and their interactions with human RNA are shown to be important in virus survival and pathogenicity.

A new smartphone app improves the reliability of on-site rapid COVID-19 colorimetric tests, paving the way for safe gatherings in the post-pandemic world.

From music streaming technology to COVID-19 tests, A*STAR Assistant Chief Executive (Enterprise) Sze Wee Tan details how the agency is bringing their innovations out of the lab and into the real world.

A*STAR’s steady investments in R&D and talent create the ideal conditions for impactful science, says its Chief Executive Officer Frederick Chew.

Contrary to popular belief, a new A*STAR study shows that HIV mutations are far from random, emerging at specific locations at specific rates.

A portable, low-cost spectrophotometer could free up scientists to perform routine experiments outside the lab.

Tracking how SARS-CoV-2 interacts with host cell receptors during infections may give us new ideas for COVID-19 drug targets.